Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Med Sci Monit ; 15(2): BR37-42, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19179959

ABSTRACT

BACKGROUND: Dobutamine is the agent of choice for increasing cardiac output during myocardial depression in humans with septic shock. Studies have shown that beta-adrenoceptor agonists influence nitric oxide generation, probably by modulating cyclic adenosine monophosphate. We investigated the effects of dobutamine on the systemic and luminal gut release of nitric oxide during endotoxic shock in rabbits. MATERIAL/METHODS: Twenty anesthetized and ventilated New Zealand rabbits received placebo or intravenous lipopolysaccharide with or without dobutamine (5 micro g/kg/min). Ultrasonic flow probes placed around the superior mesenteric artery and the abdominal aorta continuously estimated the flow. A segment from the ileum was isolated and perfused, and serum nitrate/nitrite levels were measured in the perfusate solution and the serum every hour. RESULTS: The mean arterial pressure decreased with statistical significance in the lipopolysaccharide group but not in the lipopolysaccharide/dobutamine group. The abdominal aortic flow decreased statistically significantly after lipopolysaccharide administration in both groups but recovered to baseline in the lipopolysaccharide/dobutamine group. The flow in the superior mesenteric artery was statistically significantly higher in the lipopolysaccharide/dobutamine group than in the lipopolysaccharide group at 2 hours. The serum nitrate/nitrite levels were higher in the lipopolysaccharide group and lower in the lipopolysaccharide/dobutamine group than those in the control group. The gut luminal perfusate serum nitrate/nitrite level was higher in the lipopolysaccharide group than in the lipopolysaccharide/dobutamine group. CONCLUSIONS: Dobutamine can decrease total and intestinal nitric oxide production in vivo. Those effects seem to be inversely proportional to the changes in blood flow.


Subject(s)
Dobutamine/pharmacology , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Nitric Oxide/biosynthesis , Shock, Septic/metabolism , Animals , Coronary Circulation/drug effects , Heart Rate/drug effects , Lactic Acid/blood , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/pharmacology , Nitrates/blood , Nitrites/blood , Perfusion , Rabbits , Shock, Septic/physiopathology
2.
J Immunol ; 178(11): 6700-4, 2007 Jun 01.
Article in English | MEDLINE | ID: mdl-17513713

ABSTRACT

Host resistance to Trypanosoma cruzi infection depends on a type 1 response characterized by a strong production of IL-12 and IFN-gamma. Amplifying this response through CD40 triggering results in control of parasitemia. Two newly synthesized molecules (<3 kDa) mimicking trimeric CD40L (mini CD40Ls(-1) and (-2)) bind to CD40, activate murine dendritic cells, and elicit IL-12 production. Wild-type but not CD40 knockout mice exhibited a sharp decrease of parasitemia and mortality when inoculated with T. cruzi mixed with miniCD40Ls. Moreover, the immunosuppression induced by T. cruzi infection was impaired in mice treated with miniCD40Ls, as shown by proliferation of splenic lymphocytes, percentage of CD8(+) T cells, and IFN-gamma production. Mice surviving T. cruzi infection in the presence of miniCD40L(-1) were immunized against a challenge infection. Our results indicate that CD40L mimetics are effective in vivo and promote the control of T. cruzi infection by overcoming the immunosuppression usually induced by the parasites.


Subject(s)
CD40 Ligand/physiology , Chagas Disease/immunology , Interferon-gamma/biosynthesis , Molecular Mimicry/immunology , Parasitemia/immunology , T-Lymphocyte Subsets/immunology , Animals , CD40 Antigens/metabolism , CD40 Antigens/physiology , CD40 Ligand/chemical synthesis , CD40 Ligand/deficiency , CD40 Ligand/genetics , Cell Line , Cells, Cultured , Chagas Disease/metabolism , Chagas Disease/prevention & control , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Parasitemia/metabolism , Parasitemia/prevention & control , T-Lymphocyte Subsets/metabolism , Trypanosoma cruzi/immunology
3.
Shock ; 26(2): 169-73, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16878025

ABSTRACT

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that plays a major role in the pathogenesis of sepsis. Some studies have indicated that glucocorticoids increase MIF production in physiological conditions. The goal of this study was to determine whether glucocorticoid treatment also upregulates MIF production in sepsis. Male NMRI mice (6-10 weeks old) underwent laparotomy, proximal ligation of the cecum, and double perforation with a 19-gauge needle (cecal ligation and puncture). Mice were randomly treated with saline (control) or dexamethasone at doses of 0.1, 1, or 10 mg/kg ip. At 6 or 18 h postoperatively, 10 mice per group were euthanized; and blood, peritoneal fluid, liver, lung, kidney, and heart tissue samples were retrieved. MIF, IL-6, TNF-alpha, and IL-10 were measured by enzyme-linked immunosorbent assay. Sepsis induced by cecal ligation and puncture produced a marked increase in MIF and cytokine levels in plasma and peritoneal fluid. Treatment with dexamethasone 10 mg/kg decreased MIF levels in plasma after 18 h, but there was no effect of dexamethasone on MIF production locally in the peritoneal cavity or in the liver, lungs, heart, or kidneys. We conclude that glucocorticoid treatment does not upregulate MIF production in sepsis.


Subject(s)
Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Macrophage Migration-Inhibitory Factors/metabolism , Sepsis/drug therapy , Animals , Ascitic Fluid/metabolism , Disease Models, Animal , Interleukin-10/metabolism , Interleukin-6/metabolism , Macrophage Migration-Inhibitory Factors/blood , Male , Mice , Mice, Inbred Strains , Peritoneal Lavage , Peritonitis/drug therapy , Peritonitis/metabolism , Sepsis/metabolism , Tumor Necrosis Factor-alpha/metabolism
4.
Nat Chem Biol ; 1(7): 377-82, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16370373

ABSTRACT

Interaction between CD40, a member of the tumor necrosis factor receptor (TNFR) superfamily, and its ligand CD40L, a 39-kDa glycoprotein, is essential for the development of humoral and cellular immune responses. Selective blockade or activation of this pathway provides the ground for the development of new treatments against immunologically based diseases and malignancies. Like other members of the TNF superfamily, CD40L monomers self-assemble around a threefold symmetry axis to form noncovalent homotrimers that can each bind three receptor molecules. Here, we report on the structure-based design of small synthetic molecules with C3 symmetry that can mimic CD40L homotrimers. These molecules interact with CD40, compete with the binding of CD40L to CD40, and reproduce, to a certain extent, the functional properties of the much larger homotrimeric soluble CD40L. Architectures based on rigid C3-symmetric cores may thus represent a general approach to mimicking homotrimers of the TNF superfamily.


Subject(s)
CD40 Antigens/drug effects , CD40 Ligand/drug effects , Molecular Mimicry/drug effects , Peptides/pharmacology , Animals , Apoptosis/drug effects , CD40 Antigens/biosynthesis , CD40 Antigens/chemistry , CD40 Ligand/chemistry , Cell Line , Cell Line, Tumor , Humans , Mice , Mice, Inbred BALB C , Models, Biological , Molecular Structure , Peptides/chemistry , Protein Conformation , Protein Structure, Quaternary , Structure-Activity Relationship , Time Factors
5.
Infect Immun ; 73(10): 6552-61, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16177330

ABSTRACT

We have previously shown that infection by Trypanosoma cruzi, a parasitic protozoan, is reduced by injection of CD40 ligand (CD40L)-transfected 3T3 fibroblasts (D. Chaussabel, F. Jacobs, J. de Jonge, M. de Veerman, Y. Carlier, K. Thielemans, M. Goldman, and B. Vray, Infect. Immun. 67:1929-1934, 1999). This prompted us to transfect T. cruzi with the murine CD40L gene and to study the consequences of this transfection on the course of infection. For this, epimastigotes (Y strain) were electroporated with the pTEX vector alone or the pTEX-CD40L construct, and transfected cells were selected for their resistance to Geneticin G418. Then strain Y-, pTEX-, and pTEX-CD40L-transfected epimastigotes were transformed by metacyclogenesis into mammalian infective forms called Y, YpTEX, and YpTEX-CD40L trypomastigotes. Transfection of the CD40L gene and expression of the CD40L protein were assessed by reverse transcription-PCR and Western blot analysis. The three strains of parasites were infective in vitro for mouse peritoneal macrophages. When organisms were inoculated into mice, a very low level of parasitemia and no mortality were seen with the YpTEX-CD40L strain compared to the Y and YpTEX strains. Furthermore, the proliferative capacity and the secretion of gamma interferon were both preserved in spleen cells (SCs) from YpTEX-CD40L-infected mice but not with SCs from Y- and YpTEX-infected mice. These results suggest that the CD40L produced by transfected T. cruzi is involved in the modulation of an antiparasite immune response. Moreover, mice surviving YpTEX-CD40L infection resisted a challenge infection with the wild-type strain. Taken together, our data demonstrate the feasibility of generating a T. cruzi strain expressing a bioactive host costimulatory molecule that counteracts the immunodeficiency induced by the parasite during infection and enhances protective immunity against a challenge infection.


Subject(s)
CD40 Ligand/genetics , Chagas Disease/prevention & control , Protozoan Vaccines , Trypanosoma cruzi/genetics , Trypanosoma cruzi/immunology , Animals , Antibodies, Protozoan/blood , CD40 Ligand/analysis , CD40 Ligand/biosynthesis , Cell Proliferation , Chagas Disease/immunology , Genetic Vectors/genetics , Gentamicins/pharmacology , Interferon-gamma/metabolism , Macrophages, Peritoneal/parasitology , Mice , Mice, Inbred Strains , Parasitemia/prevention & control , Protozoan Vaccines/genetics , Protozoan Vaccines/immunology , Spleen/cytology , Spleen/metabolism , Transfection , Trypanosoma cruzi/metabolism
6.
Nitric Oxide ; 12(1): 1-8, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15631941

ABSTRACT

Ethnopharmacological data from eastern African traditional uses of Plantago palmata leaves suggest that some therapeutical activities could be dependent on their content in polysaccharides (PS). To further investigate immunomodulatory properties of these PS, they were extracted in water from leaves by maceration either at (i) 50 degrees C without filtration (PS50); (ii) 50 degrees C and filtration (PS50F); (iii) 100 degrees C, without filtration (PS100); or 100 degrees C and filtration (PS100F). The extract PS50 was further fractionated by high performance liquid chromatography (gel permeation chromatography) in three fractions namely F1, F2, and F3. The immunomodulatory properties of these four crude extracts and PS50 fractions were investigated by the measurement of nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), and interleukin-10 (IL-10) production using interferon gamma-(IFN-gamma)-activated macrophages and non-activated macrophages as control. Non-activated J774 cell line macrophages, treated with any of the PS extracts, did produce neither NO, nor TNF-alpha, nor IL-10. In contrast, IFN-gamma-activated J774 macrophages synergized with PS50, but not with the three other crude extracts, to produce both NO and TNF-alpha, but not IL-10. Immunomodulatory effects due to traces of lipopolysaccharides (LPS) in PS extracts and fractions were ruled out by the use of macrophages from C3H/Hej mice known to be very low responders to LPS and similar results were obtained. In addition, F2 fraction from PS50 was particularly active in enhancing NO and TNF-alpha (but not IL-10) production by IFN-gamma-activated C3H/Hej macrophages. These results suggest that PS from P. palmata leaves possess immunomodulatory properties by stimulating NO and TNF-alpha production by activated macrophages.


Subject(s)
Macrophages/metabolism , Nitric Oxide/biosynthesis , Plant Leaves/chemistry , Plantago/chemistry , Polysaccharides/pharmacology , Tumor Necrosis Factor-alpha/biosynthesis , Animals , Cell Line , Interferon-gamma/pharmacology , Macrophage Activation/drug effects , Macrophages/drug effects , Mice , Mice, Inbred C3H , Nitric Oxide/metabolism , Polysaccharides/isolation & purification , Tumor Necrosis Factor-alpha/metabolism
7.
Glycobiology ; 14(7): 647-57, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15044384

ABSTRACT

The impact of a pathogen-induced inflammatory response on dendritic cells (DCs) and on their expression of galectin-3 (Gal-3) was studied on splenic DCs (sDCs) from Trypanosoma cruzi-infected mice. We determined the lectin expression and also presentation of ligands using the labeled galectin as probe. By reverse transcriptase polymerase chain reaction, western blot analysis, quantitative glycocytochemistry, and computer-assisted quantitative microscopy, we demonstrate that, in sDCs from infected mice, expression of Gal-3 and Gal-3-specific ligands were markedly up-regulated and adhesiveness was increased with Gal-3-coated substratum. Gal-3 expression was also enhanced in T. cruzi-infected D2SC-1 cells. To assess influence on migration, we had to work exclusively with D2SC-1 cells because sDCs rapidly lost their capacity to adhere to substratum. Migration of infected- and TCM-treated D2SC-1 cells were reduced when substratum was coated with Gal-3. Expression of Gal-3 by D2SC-1 was reduced when they were incubated with anti-Gal-3 antisense oligonucleotide without effect on cell invasion by the parasite. By using seven neoglycoconjugates, we probed the cellular capacity to specifically bind carbohydrate ligands. Similar to Gal-3, an up-regulation was noted with respect to sites specific for Man and alpha-GalNAc, respectively, revealing that infection-dependent changes are not confined to Gal-3-dependent parameters. Considered together, these data document for the first time that a parasitic infection can modulate both in vivo and in vitro the expression of Gal-3 and of ligands for this lectin in DCs with functional consequences on their capacities of adhesion and migration. These results suggest a new immunomodulatory property of T. cruzi.


Subject(s)
Cell Movement/immunology , Chagas Disease/immunology , Dendritic Cells/immunology , Galectin 3/biosynthesis , Trypanosoma cruzi/immunology , Up-Regulation , Acetylgalactosamine/metabolism , Animals , Antibodies, Protozoan/pharmacology , Cell Adhesion/drug effects , Cell Movement/drug effects , Cells, Cultured , Chagas Disease/metabolism , Dendritic Cells/metabolism , Dendritic Cells/microbiology , Ligands , Mannose/metabolism , Mice , Oligodeoxyribonucleotides, Antisense/pharmacology , Protein Binding , Spleen/cytology , Spleen/immunology , Trypanosoma cruzi/physiology , Up-Regulation/drug effects
8.
Lab Invest ; 83(9): 1373-82, 2003 Sep.
Article in English | MEDLINE | ID: mdl-13679445

ABSTRACT

Trypanosoma cruzi, the etiologic agent of Chagas disease, induces infection that affects most immunocompetent cells. However, its effect on dendritic cells (DC) is still unknown in vivo. In this report, we show, by immunohistochemical staining, that T. cruzi infection triggers a huge increase in the number of CD11c(+) DC in the spleen of infected mice at Days 14 and 21 post-inoculation (pi). In mice reaching the chronic phase (starting on Day 35 pi), the number of splenic DC (sDC) returned progressively to normal (ending on Day 98 pi). In the spleens of noninfected mice, most of the CD8alpha(+)CD11c(+) and CD8alpha(-)CD11c(+) DC were found in the red pulp and the marginal and T-cell zones. However, starting on Day 14 pi, a progressive decline of CD8alpha(+)CD11c(+) was observed. In addition, sDC expressed low levels of the costimulatory molecule B7.2 at Days 14 and 21 pi, suggesting that they remained immature in the course of the infection. As expected, in lipopolysaccharide-treated and noninfected mice, the expression of B7.2 molecules was sharply up-regulated on sDC that migrated toward the T-cell zone. In contrast, upon lipopolysaccharide stimulation, sDC from T. cruzi-infected mice did not migrate toward the T-cell zone nor did they undergo maturation. Finally, white pulp was severely depleted in both CD4(+) and CD8(+) T cells at the peak of infection. Taken together, these results indicate that profound alterations of migration and maturation of sDC and depletion/redistribution of T cells occur during the acute phase of T. cruzi infection and could be part of another strategy to escape immune surveillance and to persist in the host.


Subject(s)
Chagas Disease/immunology , Dendritic Cells/immunology , Protozoan Infections, Animal/immunology , T-Lymphocytes/immunology , Animals , Antigens, CD/analysis , Cell Movement/immunology , Chagas Disease/pathology , Dendritic Cells/parasitology , Dendritic Cells/pathology , Disease Models, Animal , Escherichia coli/immunology , Flow Cytometry , Immunophenotyping , Lipopolysaccharides/pharmacology , Mice , Mice, Inbred BALB C , Protozoan Infections, Animal/pathology , Rats , Rats, Inbred F344 , Spleen/immunology , Spleen/parasitology , Spleen/pathology , Splenomegaly/immunology , Splenomegaly/parasitology , Splenomegaly/pathology , T-Lymphocytes/parasitology , T-Lymphocytes/pathology , Trypanosoma cruzi/immunology , Trypanosoma cruzi/pathogenicity , Up-Regulation
9.
J Appl Physiol (1985) ; 95(5): 2047-54, 2003 Nov.
Article in English | MEDLINE | ID: mdl-12923122

ABSTRACT

Whether the gut alterations seen during sepsis are caused by microcirculatory hypoxia or disturbances in cellular metabolic pathways associated with mitochondrial respiration remains controversial. We hypothesized that hypoperfusion or hypoxia and local production of nitric oxide might play an important role in the development of gut mucosal injury during endotoxic shock and investigated their roles by using differing levels of fluid resuscitation and occlusion of the superior mesenteric artery (SMA). Anesthetized New Zealand rabbits were allocated to group I (sham, n = 8); group II [low-dose endotoxin (LPS, Escherichia coli-055:B5, 150 microg/kg)/fluid resuscitation (12 ml x kg(-1) x h(-1)); n = 8]; group III [high-dose LPS (1 mg/kg)/fluid resuscitation (12 ml x kg(-1) x h(-1)); n = 8]; group IV [high-dose LPS (1 mg/kg)/hypovolemia (4 ml x kg-1 x h(-1) fluids); n = 8]; and group V [SMA ligation/fluid resuscitation (12 ml x kg(-1) x h(-1)); n = 4]. Luminal gut lactate concentrations and PCO2 gap increased in groups IV and V (P < 0.05), reflecting alterations in gut perfusion. Interestingly, significant histological alterations were observed in all LPS groups but not in group V. Blood and luminal gut nitrate/nitrite concentrations increased only in group IV. The mechanism of gut injury in endotoxic shock seems unrelated to hypoxia and release of nitric oxide. Gut dysfunction may occur as a result of so-called "cytopathic hypoxia."


Subject(s)
Intestinal Mucosa/pathology , Ischemia/pathology , Shock, Septic/pathology , Animals , Blood Pressure , Carbon Dioxide/blood , Ileum/blood supply , Ileum/metabolism , Ileum/pathology , Intestinal Mucosa/blood supply , Intestinal Mucosa/metabolism , Ischemia/metabolism , Lactic Acid/blood , Lipopolysaccharides/pharmacology , Nitrates/blood , Nitric Oxide/metabolism , Nitrites/blood , Rabbits , Regional Blood Flow , Sepsis/metabolism , Sepsis/pathology , Shock, Septic/metabolism , Specific Pathogen-Free Organisms
10.
Vesalius ; 8(1): 45-52, 2002 Jun.
Article in French | MEDLINE | ID: mdl-12422887

ABSTRACT

By demonstrating, in 1910, the presence of eggs of schistosomes in the kidneys of Egyptian mummies of the XXth Dynasty, Marc Armand Ruffer is considered as the founder of paleoparasitology. One century later, thanks to technologies derived from molecular biology, important advances have been made in the history of human parasitic diseases, especially in the fields of schistosomiasis, trypanosomiasis and leishmaniasis. For instance, it is probable that there was a common ancestor for the three main groups of schistosoma species which infect humans and animals today. Similarly, it is likely that South American and African trypanosomes arose from a common ancestral protozoa. This hypothesis is further sustained by the characterization of a protein (CCF-1 for Coelomic Cytolytic Factor-1), isolated from an annelid and which binds molecules expressed by two distinct species of trypanosoma. Lastly, recent data highlight the geographic distribution of various species of Leishmania in both the Old and the New World. Improvement in parasite phylogeny and systematics lead to a better understanding of the history of human parasitic diseases.


Subject(s)
Molecular Biology/history , Paleopathology/history , Parasitology/history , History, 20th Century , History, 21st Century
11.
Int Immunol ; 14(10): 1135-44, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12356679

ABSTRACT

Trypanosoma cruzi, the etiological agent of Chagas' disease, may persist for many years in its mammalian host. This suggests escape from the immune response and particularly a suboptimal CD8(+) T cell response, since these cells are involved in infection control. In this report, we show that T. cruzi inhibits the lipopolysaccharide (LPS)-induced up-regulation of MHC class I molecules at the surface of human dendritic cells (DC). To further investigate the functional consequences of this inhibition, a trypomastigote surface antigen-derived peptide (TSA-1(514-522) peptide) was selected for its stable binding to HLA-A*0201 molecules and used to generate a primary T. cruzi-specific human CD8(+) T cell line in vitro. We observed that DC infected with T. cruzi or treated with T. cruzi-conditioned medium (TCM) had a weaker capacity to present this peptide to the specific CD8(+) T cell line as shown in an IFN-gamma ELISPOT assay. Interestingly, T. cruzi or TCM also reduced the antigen presentation capacity of DC to CD8(+) T cell lines specific for the influenza virus M(58-66) or HIV RT(476-484) epitopes. This dysfunction appears to be linked essentially to reduced MHC class I molecule expression since the stimulation of the RT(476-484) peptide-specific CD8(+) T cell line was shown to depend mainly on the MHC class I-TCR interaction and not on the co-stimulatory signals which, however, were also inhibited by T. cruzi. This impairment of DC function may represent a novel mechanism reducing in vivo the host's ability to combat efficiently T. cruzi infection.


Subject(s)
Antigen Presentation , CD8-Positive T-Lymphocytes/immunology , Dendritic Cells/immunology , Histocompatibility Antigens Class I/biosynthesis , Trypanosoma cruzi/immunology , Animals , CD28 Antigens/physiology , CD40 Antigens/physiology , Cell Line , Culture Media, Conditioned , Down-Regulation , Humans , Immunophenotyping , Lipopolysaccharides/pharmacology , Lymphocyte Activation
12.
Parasite Immunol ; 24(5): 253-62, 2002 May.
Article in English | MEDLINE | ID: mdl-12060319

ABSTRACT

Cystatins of two filarial nematodes were studied with regard to their capacity to up-regulate the production of nitric oxide (NO) in vitro, and the effects were analysed. Recombinant cystatin of the human pathogenic filaria Onchocerca volvulus and of the rodent filaria Acanthocheilonema viteae significantly enhanced the NO production of interferon (IFN)-gamma-activated macrophages of BALB/c and C3H/HeJ mice. Truncated cystatins lacking the N-terminal protease inhibitory active site, and showing marginal protease inhibitory activity, up-regulated the NO production to the same extent as the full-length proteins, indicating that the effect on the NO production is independent of cysteine protease inhibition. NO did not contribute to the suppression of proliferative T cell responses exerted by filarial cystatins, as shown in other studies, since NO synthase inhibitors did not restore proliferative responses. The up-regulation of NO production induced by filarial cystatins was partly dependent on the production of interleukin-10 and tumour necrosis factor-alpha, since depletion of both cytokines by antibodies led to a diminution of the enhanced NO production by 22-48%. Our data suggest that filarial cystatins are potent triggers of the production of NO, a mediator which was shown to have a role as an effector molecule against filarial worms in vitro and in vivo.


Subject(s)
Cystatins/pharmacology , Dipetalonema/metabolism , Interferon-gamma/pharmacology , Macrophage Activation , Mice , Nitric Oxide/biosynthesis , Onchocerca volvulus/metabolism , Adjuvants, Immunologic/metabolism , Animals , Cystatins/metabolism , Filariasis/immunology , Interleukin-10/metabolism , Life Cycle Stages , Polysaccharides, Bacterial/metabolism , T-Lymphocytes/metabolism , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation
13.
Dev Comp Immunol ; 26(1): 27-34, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11687260

ABSTRACT

A cytolytic protein named Coelomic Cytolytic Factor-1 (CCF-1) was isolated from the coelomic fluid of the earthworm Eisenia foetida foetida. Despite the absence of any gene homology, CCF-1 showed functional analogy with the mammalian cytokine tumour necrosis factor (TNF), particularly based on similar lectin-like activity. Indeed, both CCF-1 and TNF recognise N,N'-diacetylchitobiose and exert lytic activity on African Trypanosoma brucei brucei. In this report, we show that South-American Trypanosoma cruzi trypomastigotes, but not epimastigotes, were lysed by earthworm coelomic fluid or purified CCF-1. However, T. cruzi was less susceptible to lysis than T. brucei brucei. This lytic effect of coelomic fluid and CCF-1 on T. cruzi trypomastigotes was partially inhibited in the presence of anti-CCF-1 monoclonal antibody, antibody neutralising the lectin-like activity of TNF or N,N'-diacetylchitobiose. In contrast, this lytic effect was completely inhibited when using T. b. brucei. In addition, T. cruzi components, upon recognition by CCF-1 in E. f. foetida coelomic fluid, triggered the prophenoloxidase cascade, an invertebrate defence mechanism. These results further extend the functional analogies of CCF-1 and TNF, suggesting that both molecules share a similar lectin-like activity that has been conserved as an innate recognition mechanism in invertebrates and vertebrates. They also establish a link between stercorarian (T. cruzi) and salivarian (T. brucei) trypanosomatids having divergent phylogenetic origins and patterns of evolution, but possessing closely related cell surface sugar moieties.


Subject(s)
Cytotoxins/pharmacology , Lectins , Oligochaeta/immunology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Tumor Necrosis Factor-alpha , Animals , Body Fluids/immunology , Catechol Oxidase/metabolism , Cytotoxins/genetics , Enzyme Activation , Enzyme Precursors/metabolism , Oligochaeta/parasitology , Recombinant Proteins/pharmacology , Trypanosoma brucei brucei/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...